Methylphenidate-induced activation of the anterior cingulate but not the striatum: A [15O]H2O PET study in healthy volunteers

Human Brain Mapping

Volumn 28, Issue 7, 2007, Pages 625-635

  Udo De Haes, Joanna I ^a,c   Maguire, R Paul ^a,b   Jager, Piet L ^a   Paans, Anne M J ^a   Den Boer, Johan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c NV Organon ^*  (Netherlands)

Author keywords

Dopamine; Emotions; Humans; Methylphenidate; Regional cerebral blood flow

Indexed keywords

DOPAMINE; DOPAMINE UPTAKE INHIBITOR; GROWTH HORMONE; METHYLPHENIDATE; PLACEBO; WATER O 15;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN MAPPING; CINGULATE GYRUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NEUROMODULATION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

ADULT; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOUBLE-BLIND METHOD; FEMALE; GROWTH HORMONE; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; METHYLPHENIDATE; OXYGEN RADIOISOTOPES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 34447343096     PISSN: 10659471     EISSN: None     Source Type: Journal    
DOI: 10.1002/hbm.20293     Document Type: Article

References (115)

1. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P (2001): The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci 935:107-117.
2. Attwell D, Laughlin SB (2001): An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21:1133-1145.
3. Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, Schmauss C, Zakharenko SS, Zablow L, Sulzer D (2004): Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42:653-663.
4. Beauregard M, Levesque J, Bourgouin P (2001): Neural correlates of conscious self-regulation of emotion. J Neurosci 21:RC165.
5. Berger B, Trottier S, Verney C, Gaspar P, Alvarez C (1988): Regional and laminar distribution of the dopamine and serotonin innervation in the macaque cerebral cortex: a radioautographic study. J Comp Neurol 273:99-119.
6. Berman KF, Weinberger DR (1990): Lateralisation of cortical function during cognitive tasks: regional cerebral blood flow studies of normal individuals and patients with schizophrenia. J Neurol Neurosurg Psychiatry 53:150-160.
7. Berthoz S, Blair RJR (2002): Emotions: from neuropsychology to functional imaging. Int J Psychol 37:193-203.
8. Black KJ, Hershey T, Koller JM, Videen TO, Mintun MA, Price JL, Perlmutter JS (2002): A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc Natl Acad Sci U S A 99:17113-17118.
9. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, Matochik J, Kurian V, Cadet J, Kimes A, Funderburk F, London E (2004): Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci 16:456-464.
10. Boshuisen ML, Ter-Horst GJ, Paans AM, Reinders AA, den-Boer JA (2002): rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biol Psychiatry 52:126-135.
11. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman JM, Kantor HL, Gastfriend DR, Riorden JP, Mathew RT, Rosen BR, Hyman SE (1997): Acute effects of cocaine on human brain activity and emotion. Neuron 19:591-611.
12. Brett M, Anton JL, Valabregue R, Poline JB (2002): Region of interest analysis using an SPM toolbox. Presented at the 8th International Conference on Functional Mapping of the Human Brain, June 2-6, 2002, Sendai, Japan. Neuroimage 16:497.
13. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S (1990): Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br J Psychiatry 156:216-227.
14. Bush G, Luu P, Posner M (2000): Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4:215-222.
15. Canli T, Zhao Z, Desmond JE, Kang E, Gross J, Gabrieli JD (2001): An fMRI study of personality influences on brain reactivity to emotional stimuli. Behav Neurosci 115:33-42.
16. Cash D, Read SJ, Lythgoe D, Williams SCR, Roberts TJ, Ireland MD, Smart SC, Hunter AJ (2003): Autoradiographic and functional MRI assessment of rat brain response to amphetamine under halothane and alpha-chloralose anaesthesia. J Cereb Blood Flow Metab 23:31.
17. Cattapan-Ludewig K, Hilti CC, Ludewig S, Vollenweider FX, Feldon J (2005): Rapid visual information processing in schizophrenic patients: the impact of cognitive load and duration of stimulus presentation. A pilot study. Neuropsychobiology 52:130-134.
18. Cepeda C, Buchwald NA, Levine MS (1993): Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci U S A 90:9576-9580.
19. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG (1997): Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med 38:389-398.
20. Childress AR, Wang Z, Sciortino N, Detre J, Germain A, Hole A, MacDougall M, Vietri J, O'Brien CP (2004): Brain substrates of "attempted" vs. "successful" inhibition of cue-induced craving for cocaine vs. sex. Soc Neurosci Abstr 464.6.
21. Corbetta M, Shulman GL (2002): Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 3:201-215.
22. Coull JT, Frackowiak RS, Frith CD (1998): Monitoring for target objects: activation of right frontal and parietal cortices with increasing time on task. Neuropsychologia 36:1325-1334.
23. Damasio AR, Grabowski TJ, Bechara A, Damasio H, Ponto LL, Parvizi J, Hichwa RD (2000): Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci 3:1049-1056.
24. Devinsky O, Morrell MJ, Vogt BA (1995): Contributions of anterior cingulate cortex to behaviour. Brain 118(Pt 1):279-306.
25. Dixon AL, Prior M, Morris PM, Shah YB, Joseph MH, Young AM (2005): Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48:236-245.
26. Dolan RJ, Lane R, Chua P, Fletcher P (2000): Dissociable temporal lobe activations during emotional episodic memory retrieval. Neuroimage 11:203-209.
27. Drevets WC (1999): Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 877:614-637.
28. During MJ, Bean AJ, Roth RH (1992): Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex. Neurosci Lett 140:129-133.
29. Ebert D, Ebmeier KP (1996): The role of the cingulate gyrus in depression: from functional anatomy to neurochemistry. Biol Psychiatry 39:1044-1050.
30. Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, Spetsieris P, Alterman R, Kelly PJ, Dogali M, Fazzini E, Beric A (1997): Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 120:1315-1324.
31. Ernst M, Zametkin AJ, Matochik J, Schmidt M, Jons PH, Liebenauer LL, Hardy KK, Cohen RM (1997): Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology 17:391-401.
32. Fonnum F, Storm-Mathisen J, Divac I (1981): Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain. Neuroscience 6:863-873.
33. Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA, O'Brien CP, Childress AR (2002): Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry 51:134-142.
34. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ (1995): Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189-210.
35. Gamma A, Buck A, Berthold T, Liechti ME, Vollenweider FX (2000): 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2](15)O)-PET in healthy humans. Neuropsychopharmacology 23:388-395.
36. Gaspar P, Berger B, Febvret A, Vigny A, Henry JP (1989): Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol 279:249-271.
37. Geurts FJ, De-Schutter E, Dieudonne S (2003): Unraveling the cerebellar cortex: cytology and cellular physiology of large-sized interneurons in the granular layer. Cerebellum 2:290-299.
38. Goldstein RZ, Volkow ND (2002): Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642-1652.
39. Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Bull U, Sass H (1999): Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology 20:565-581.
40. Hager F, Volz HP, Gaser C, Mentzel HJ, Kaiser WA, Sauer H (1998): Challenging the anterior attentional system with a continuous performance task: a functional magnetic resonance imaging approach. Eur Arch Psychiatry Clin Neurosci 248:161-170.
41. Hazeltine E, Poldrack R, Gabrieli JD (2000): Neural activation during response competition. J Cogn Neurosci 12(Suppl 2):118-129.
42. Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser-Sinopoli SM, Flor H, Braus DF, Buchholz HG, Grunder G, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P (2004): Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 161:1783-1789.
43. Herscovitch P (2001): Can [15O] water be used to evaluate drugs? J Clin Pharmacol Suppl:11S-20S.
44. Howell LL, Hoffman JM, Votaw JR, Landrum AM, Wilcox KM, Lindsey KP (2002): Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys. Psychopharmacology (Berl) 159:154-160.
45. Huff JK, Davies MI (2002): Microdialysis monitoring of methylphenidate in blood and brain correlated with changes in dopamine and rat activity. J Pharm Biomed Anal 29:767-777.
46. Ikemoto S, Panksepp J (1999): The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 31:6-41.
47. Jackson ME, Moghaddam B (2001): Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J Neurosci 21:676-681.
48. Janowsky DS, Davis JM (1976): Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. Arch Gen Psychiatry 33:304-308.
49. Janowsky DS, Leichner P, Parker D, Judd L, Huey L, Clopton P (1978): The effect of methylphenidate on serum growth hormone: influence of antipsychotic drugs and diagnosis. Arch Gen Psychiatry 35:1384-1389.
50. Johnson DL, Wiebe JS, Gold SM, Andreasen NC, Hichwa RD, Watkins GL, Boles-Ponto LL (1999): Cerebral blood flow and personality: a positron emission tomography study. Am J Psychiatry 156:252-257.
51. Joyce PR, Donald RA, Nicholls MG, Livesey JH, Abbott RM (1986): Endocrine and behavioural responses to methylpheni-date in depression. Psychol Med 16:531-540.
52. Kadekaro M, Crane AM, Sokoloff L (1985): Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat Proc Natl Acad Sci U S A 82:6010-6013.
53. Kahn DA, Prohovnik I, Lucas LR, Sackeim HA (1989): Dissociated effects of amphetamine on arousal and cortical blood flow in humans. Biol Psychiatry 25:755-767.
54. Kalivas PW, McFarland K (2003): Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168:44-56.
55. Kapur S (2003): Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160:13-23.
56. Kapur S, Mamo D (2003): Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 27:1081-1090.
57. Kiyatkin EA, Rebec GV (1996): Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. J Neurophysiol 75:142-153.
58. Kuczenski R, Segal DS (1997): Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68:2032-2037.
59. Kumari V, Mitterschiffthaler MT, Teasdale JD, Malhi GS, Brown RG, Giampietro V, Brammer MJ, Poon L, Simmons A, Williams SC, Checkley SA, Sharma T (2003): Neural abnormalities during cognitive generation of affect in treatment-resistant depression. Biol Psychiatry 54:777-791.
60. Kunig G, Leenders KL, Martin-Solch C, Missimer J, Magyar S, Schultz W (2000): Reduced reward processing in the brains of Parkinsonian patients. Neuroreport 11:3681-3687.
61. Lane RD, Fink GR, Chau PM, Dolan RJ (1997): Neural activation during selective attention to subjective emotional responses. Neuroreport 8:3969-3972.
62. Leenders KL (2002): Disease process and drug treatments in Parkinson's disease. Eur Neuropsychopharmacol 12:575-580.
63. London ED, Cascella NG, Wong DF, Phillips RL, Dannals RF, Links JM, Herning R, Grayson R, Jaffe JH, Wagner HN Jr (1990a): Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry 47:567-574.
64. London ED, Wilkerson G, Ori C, Kimes AS (1990b): Central action of psychomotor stimulants on glucose utilization in extrapyramidal motor areas of the rat brain. Brain Res 512:155-158.
65. Luppino G, Matelli M, Camarda R, Rizzolatti G (1993): Corticocortical connections of area F3 (SMA-proper) and area F6 (preSMA) in the macaque monkey. J Comp Neurol 338:114-140.
66. Marota JJ, Mandeville JB, Weisskoff RM, Moskowitz MA, Rosen BR, Kosofsky BE (2000): Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat. Neuroimage 11:13-23.
67. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT (1997): Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8:1057-1061.
68. McCulloch J (1982): Mapping functional alterations in the CNS with [14C]deoxyglucose. In: Iverson LL, Iverson SD, Snyder SH, editors. Handbook of psychopharmacology: new techniques in psychopharmacology 15. New York: Plenum. p 321-410.
69. McCulloch J, Savaki HE, Sokoloff L (1980): Influence of dopaminergic systems on the lateral habenular nucleus of the rat. Brain Res 194:117-124.
70. McCulloch J, Kelly PA, Ford I (1982): Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis). J Cereb Blood Flow Metab 2:487-499.
71. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW (2000): Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20:RC65.
72. Morari M, Marti M, Sbrenna S, Fuxe K, Bianchi C, Beani L (1998): Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem Int 33:383-397.
73. Naranjo CA, Tremblay LK, Busto UE (2001): The role of the brain reward system in depression. Prog Neuropsychopharmacol Biol Psychiatry 25:781-823.
74. Ochsner KN, Ray RD, Cooper JC, Robertson ER, Chopra S, Gabrieli JD, Gross JJ (2004): For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage 23:483-499.
75. Pardo JV, Fox PT, Raichle ME (1991): Localization of a human system for sustained attention by positron emission tomography. Nature 349:61-64.
76. Phillips ML, Drevets WC, Rauch SL, Lane R (2003): Neurobiology of emotion perception. 1. The neural basis of normal emotion perception. Biol Psychiatry 54:504-514.
77. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, Davidson RJ (2001): Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 158:405-415.
78. Poline JB, Vandenberghe R, Holmes AP, Friston KJ, Frackowiak RS (1996): Reproducibility of PET activation studies: lessons from a multi-center European experiment. EU concerted action on functional imaging. Neuroimage 4:34-54.
79. Pontieri FE, Crane AM, Seiden LS, Kleven MS, Porrino LJ (1990): Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats. Psychopharmacology (Berl) 102:175-182.
80. Porrino LJ (1993): Functional consequences of acute cocaine treatment depend on route of administration. Psychopharmacology (Berl) 112:343-351.
81. Porrino LJ, Lucignani G (1987): Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate. Relevance to its action in hyperactive children. Biol Psychiatry 22:126-138.
82. Posner MI, Rothbart MK (1998): Attention, self-regulation and consciousness. Philos Trans R Soc Lond B Biol Sci 353:1915-1927.
83. Rapoport M, van-Reekum R, Mayberg H (2000): The role of the cerebellum in cognition and behavior: a selective review. J Neuropsychiatry Clin Neurosci 12:193-198.
84. Schmahmann JD (2004): Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 16:367-378.
85. Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt LG, Heinz A (2001): Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence. Pharmacopsychiatry 34:66-72.
86. Schwartz WJ, Smith CB, Davidsen L, Savaki H, Sokoloff L, Mata M, Fink DJ, Gainer H (1979): Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science 205:723-725.
87. Schwarz AJ, Zocchi A, Reese T, Gozzi A, Garzotti M, Varnier G, Curcuruto O, Sartori I, Girlanda E, Biscaro B, Crestan V, Bertani S, Heidbreder C, Bifone A (2004): Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration. Neuroimage 23:296-304.
88. Schweighofer N, Doya K, Kuroda S (2004): Cerebellar aminergic neuromodulation: towards a functional understanding. Brain Res Brain Res Rev 44:103-116.
89. Spanagel R, Weiss F (1999): The dopamine hypothesis of reward: past and current status. Trends Neurosci 22:521-527.
90. Stein EA, Fuller SA (1993): Cocaine's time action profile on regional cerebral blood flow in the rat. Brain Res 626:117-126.
91. Sugiura M, Kawashima R, Nakagawa M, Okada K, Sato T, Goto R, Sato K, Ono S, Schormann T, Zilles K, Fukuda H (2000): Correlation between human personality and neural activity in cerebral cortex. Neuroimage 11(5 Pt 1):541-546.
92. Toma K, Honda M, Hanakawa T, Okada T, Fukuyama H, Ikeda A, Nishizawa S, Konishi J, Shibasaki H (1999): Activities of the primary and supplementary motor areas increase in preparation and execution of voluntary muscle relaxation: an event-related fMRI study. J Neurosci 19:3527-3534.
93. Tracey I (2001): Prospects for human pharmacological functional magnetic resonance imaging (phMRI). J Clin Pharmacol Suppl:21S-28S.
94. Trugman JM, James CL (1993): D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation. Brain Res 607:270-274.
95. Tschanz JT, Griffith KE, Haracz JL, Rebec GV (1994): Cortical lesions attenuate the opposing effects of amphetamine and haloperidol on neostriatal neurons in freely moving rats. Eur J Pharmacol 257:161-167.
96. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002): Automated anatomical labeling of activations in SPM using a macroscopic anatomical panellation of the MNI MRI single-subject brain. Neuroimage 15:273-289.
97. Udo de Haes JI, Kortekaas R, van Waarde A, Maguire RP, Pruim J, den Boer JA (2005): Assessment of methylphenidate-induced changes in binding of continuously infused [(11]C)-raclopride in healthy human subjects: correlation with subjective effects. Psychopharmacology 183:322-330.
98. Ullsperger M, von-Cramon DY (2003): Error monitoring using external feedback: specific roles of the habenular complex, the reward system, and the cingulate motor area revealed by functional magnetic resonance imaging. J Neurosci 23:4308-4314.
99. Ungless MA (2004): Dopamine: the salient issue. Trends Neurosci 27:702-706.
100. Van-Leeuwen TH, Steinhausen HC, Overtoom CC, Pascual-Marqui RD, van't-Klooster B, Rothenberger A, Sergeant JA, Brandeis D (1998): The continuous performance test revisited with neuroelectric mapping: impaired orienting in children with attention deficits. Behav Brain Res 94:97-110.
101. Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R, Burr G, Cooper T, Wolf A (1994): Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 16:255-262.
102. Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N (1997): Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154:50-55.
103. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Gatley J, Ding YS, Wong C, Pappas N (1998): Differences in regional brain metabolic responses between single and repeated doses of methylphenidate. Psychiatry Res 83:29-36.
104. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann R, Pappas NR (1999): Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther 291:409-415.
105. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ (2002): Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem 78:610-624.
106. Vollenweider FX, Maguire RP, Leenders KL, Mathys K, Angst J (1998): Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Psychiatry Res 83:149-162.
107. Vollm BA, de-Araujo IE, Cowen PJ, Rolls ET, Kringelbach ML, Smith KA, Jezzard P, Heal RJ, Matthews PM (2004): Methamphetamine activates reward circuitry in drug naive human subjects. Neuropsychopharmacology 29:1715-1722.
108. Wallace EA, Wisniewski G, Zubal G, vanDyck CH, Pfau SE, Smith EO, Rosen MI, Sullivan MC, Woods SW, Kosten TR (1996): Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology (Berl) 128:17-20.
109. Wang GJ, Volkow ND, Fowler JS, Ferrieri R, Schlyer DJ, Alexoff D, Pappas N, Lieberman J, King P, Warner D, Wong C, Hitzemann RJ, Wolf AP (1994): Methylphenidate decreases regional cerebral blood flow in normal human subjects. Life Sci 54:PL143-146.
110. Wang G-J, Volkow ND, Hitzemann RJ, Wong C, Angrist B, Burr G, Pascani K, Pappas N, Lu A, Cooper T, Lieberman JA (1997): Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. Eur Addict Res 3:9-54.
111. Wang GJ, Volkow ND, Fowler JS, Logan J, Pappas NR, Wong CT, Hitzemann RJ, Netusil N (1999): Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate. J Nucl Med 40:1285-1291.
112. Wise RA (2004): Dopamine, learning and motivation. Nat Rev Neurosci 5:483-494.
113. Wolkin A, Angrist B, Wolf A, Brodie J, Wnlkin B, jaeger J, Cancro R, Rotrosen J (1987): Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacnlogv (Berl) 92:241-246.
114. Wu J, Buchsbaum MS, Gillin JC, Tang C, Cadwell S, Wiegand M, Najafi A, Klein E, Hazen K, Bunney WE Jr, Fallon JH, Keator D (1999): Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 156:1149-1158.
115. Zubieta JK, Ketter TA, Bueller JA, Xu Y, Kilbourn MR, Young EA, Koeppe RA (2003): Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry 60:1145-1153.